SPARC vs RELIANCE
Head-to-head DCF comparison · SUN PHARMA ADV.RES.CO.LTD vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 4 of 4model metrics · not investment advice
SPARC
SUN PHARMA ADV.RES.CO.LTD
General/Diversified
₹138
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,328
Above Fair Value| Metric | SPARC | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Above Fair Value |
| YieldIQ Score | 15/100 | 58/100 |
| Fair Value | ₹0 | ₹980 |
| Current Price | ₹138 | ₹1,328 |
| Margin of Safety | -100.0% | -26.2% |
| Moat | None | Wide |
| Piotroski F-Score | 4/9 | 6/9 |
| ROE | — | 6.9% |
| Debt / Equity | — | — |
| EV / EBITDA | — | 14.3× |
| Market Cap | ₹4,482 Cr | ₹17.97 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.